Genotype and Phenotype Guided Supplementation of TAMoxifen Standard Therapy With ENDOXifen in Breast Cancer Patients
Clinical trial NCT03931928 · COMPLETED
Trial details
- NCT number
- NCT03931928
- Sponsor
- Robert Bosch Gesellschaft für Medizinische Forschung mbH (RBMF)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-10
- Primary completion
- 2021-05-03
- Enrollment
- 356
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.